Updated results of a phase 1 study of EGF816, a third-generation, mutant-selective EGFR tyrosine kinase inhibitor (TKI), in advanced non-small cell lung cancer (NSCLC) harboring T790M.

Author:

Tan Daniel Shao-Weng1,Yang James Chih-Hsin2,Leighl Natasha B.3,Riely Gregory J.4,Sequist Lecia V.5,Felip Enriqueta6,Seto Takashi7,Wolf Juergen8,Moody Susan Elizabeth9,Adams Kenneth9,Schmitz Shu-Fang Hsu10,Tan Eugene Y.11,Kim Dong-Wan12

Affiliation:

1. National Cancer Centre, Singapore, Singapore;

2. National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Taiwan;

3. Princess Margaret Cancer Centre, University Health Network, Division of Medical Oncology and Hematology, Toronto, ON, Canada;

4. Memorial Sloan Kettering Cancer Center, New York, NY;

5. Massachusetts General Hospital, Boston, MA;

6. Vall d'Hebron University, Barcelona, Spain;

7. National Kyushu Cancer Center, Fukuoka, Japan;

8. Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University Hospital Cologne, Cologne, Germany;

9. Novartis Institutes for BioMedical Research, Cambridge, MA;

10. Novartis Pharma AG, Basel, Switzerland;

11. Novartis Pharmaceuticals Corporation, East Hanover, NJ;

12. Seoul National University Hospital, Seoul, South Korea;

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3